EP1089732A4 - Zusammenstellungen und methoden zur behandlung von erhöhtem blutcholesterolspiegel - Google Patents
Zusammenstellungen und methoden zur behandlung von erhöhtem blutcholesterolspiegelInfo
- Publication number
- EP1089732A4 EP1089732A4 EP99930452A EP99930452A EP1089732A4 EP 1089732 A4 EP1089732 A4 EP 1089732A4 EP 99930452 A EP99930452 A EP 99930452A EP 99930452 A EP99930452 A EP 99930452A EP 1089732 A4 EP1089732 A4 EP 1089732A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- compositions
- methods
- blood cholesterol
- elevated blood
- treating elevated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/005—Enzyme inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US9040498P | 1998-06-24 | 1998-06-24 | |
US90404P | 1998-06-24 | ||
GBGB9817174.7A GB9817174D0 (en) | 1998-08-06 | 1998-08-06 | Compositions and methods for treating elevated blood cholesterol |
GB9817174 | 1998-08-06 | ||
PCT/US1999/013888 WO1999066930A1 (en) | 1998-06-24 | 1999-06-21 | Compositions and methods for treating elevated blood cholesterol |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1089732A1 EP1089732A1 (de) | 2001-04-11 |
EP1089732A4 true EP1089732A4 (de) | 2001-09-19 |
Family
ID=26314177
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP99930452A Withdrawn EP1089732A4 (de) | 1998-06-24 | 1999-06-21 | Zusammenstellungen und methoden zur behandlung von erhöhtem blutcholesterolspiegel |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1089732A4 (de) |
JP (1) | JP2002518449A (de) |
AU (1) | AU4699099A (de) |
CA (1) | CA2336192A1 (de) |
WO (1) | WO1999066930A1 (de) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6492170B1 (en) | 2000-09-11 | 2002-12-10 | Isis Pharmaceuticals, Inc. | Antisense modulation of caspase 9 expression |
US6566135B1 (en) | 2000-10-04 | 2003-05-20 | Isis Pharmaceuticals, Inc. | Antisense modulation of caspase 6 expression |
WO2002034261A1 (fr) * | 2000-10-23 | 2002-05-02 | Sankyo Company, Limited | Compositions hypocholesterolemiantes |
AR040588A1 (es) | 2002-07-26 | 2005-04-13 | Schering Corp | Formulacion farmaceutica que comprende un inhibidor de la absorcion del colesterol y un inhibidor de una hmg- co a reductasa |
-
1999
- 1999-06-21 AU AU46990/99A patent/AU4699099A/en not_active Abandoned
- 1999-06-21 WO PCT/US1999/013888 patent/WO1999066930A1/en not_active Application Discontinuation
- 1999-06-21 CA CA002336192A patent/CA2336192A1/en not_active Abandoned
- 1999-06-21 JP JP2000555616A patent/JP2002518449A/ja not_active Withdrawn
- 1999-06-21 EP EP99930452A patent/EP1089732A4/de not_active Withdrawn
Non-Patent Citations (4)
Title |
---|
HUGHES DAVID E ET AL: "Involvement of the mevalonate pathway in osteoclast apoptosis and the mechanism of action of bisphosphonates.", BONE (NEW YORK), vol. 20, no. 4 SUPPL., 1997, 25th European Symposium on Calcified Tissues;Harrogate, England, UK; April 25-29, 1997, pages 110S, XP002172609, ISSN: 8756-3282 * |
RUDEL T: "CASPASE INHIBITORS IN PREVENTION OF APOPTOSIS CASPASEINHIBITOREN ZUR PRAEVENTION VON APOPTOSE", HERZ,URBAN UND VOGEL, MUENCHEN,DE, vol. 24, no. 3, 1994, pages 236 - 241, XP001009833, ISSN: 0340-9937 * |
See also references of WO9966930A1 * |
WU J C ET AL: "IRREVERSIBLE CASPASE INHIBITORS: TOOLS FOR STUDYING APOPTOSIS", METHODS: A COMPANION TO METHODS IN ENZYMOLOGY,ACADEMIC PRESS INC., NEW YORK, NY,US, vol. 17, no. 4, 1999, pages 320 - 328, XP001000619, ISSN: 1046-2023 * |
Also Published As
Publication number | Publication date |
---|---|
JP2002518449A (ja) | 2002-06-25 |
EP1089732A1 (de) | 2001-04-11 |
AU4699099A (en) | 2000-01-10 |
WO1999066930A1 (en) | 1999-12-29 |
CA2336192A1 (en) | 1999-12-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL112593A0 (en) | Methods for inhibiting bone loss and lowering serum cholesterol | |
HK1048949A1 (en) | Method and composition for the treatment of scars | |
EP1083835A4 (de) | Methoden und geräte zur vaskularen chirurgie | |
HK1031174A1 (en) | Compositions and methods for treating diabetes | |
AU6872498A (en) | Method and composition for skin treatment | |
EP1217963A4 (de) | Vorrichtungen und verfahren zur behandlung von gewebe | |
NZ514350A (en) | Compositions and methods for effecting the levels of cholesterol | |
EP1022945A4 (de) | Verfahren und formulierung zur behandlung von gefässerkrankungen | |
AU3387599A (en) | Methods and compositions for tissue regeneration | |
IL142906A0 (en) | Methods and compositions for treating or preventing peripheral neuropathies | |
IL115405A0 (en) | Compositions and methods for treating mast-cell mediated conditions | |
IL140989A0 (en) | Compositions and methods for treating osteoporosis and lowering cholesterol | |
ZA988016B (en) | Compounds methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage | |
EP1109548A4 (de) | Zusammensetzungen und verfahren zur behandlung und vorbeugung von knochenkrankheiten unter verwendung von tocotrienole | |
ZA981600B (en) | Methods and compositions for treating stickies | |
EP1089731A4 (de) | Zusammensetzungen und verfahren zur behandlung von erhöhtem blutcholesterolspiegel | |
AU5594398A (en) | Methods and compositions for preventing and treating bone loss | |
PL349514A1 (en) | Agents and method for treating keratinous fibres | |
EP1089732A4 (de) | Zusammenstellungen und methoden zur behandlung von erhöhtem blutcholesterolspiegel | |
AU5791698A (en) | Methods and compositions for preventing and treating bone loss | |
GB9817167D0 (en) | Compositions and methods for treating elevated blood cholesterol | |
GB9817174D0 (en) | Compositions and methods for treating elevated blood cholesterol | |
AU5169200A (en) | Methods and compositions for treating breakthrough pain | |
AU5097099A (en) | Methods and compositions for cancer treatment | |
PL345261A1 (en) | Method of treatment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20010124 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU NL PT SE |
|
AX | Request for extension of the european patent |
Free format text: AL PAYMENT 20010124;LT PAYMENT 20010124;LV PAYMENT 20010124;MK PAYMENT 20010124;RO PAYMENT 20010124;SI PAYMENT 20010124 |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20010806 |
|
AK | Designated contracting states |
Kind code of ref document: A4 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU NL PT SE |
|
17Q | First examination report despatched |
Effective date: 20011120 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20020603 |